PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $391,000 | -16.1% | 10,259 | -4.2% | 0.00% | -33.3% |
| Q2 2019 | $466,000 | -69.9% | 10,709 | -73.7% | 0.00% | -62.5% |
| Q1 2019 | $1,549,000 | +11.1% | 40,688 | +25.6% | 0.01% | 0.0% |
| Q4 2018 | $1,394,000 | -24.5% | 32,402 | -13.8% | 0.01% | -11.1% |
| Q3 2018 | $1,847,000 | +26.8% | 37,583 | -17.3% | 0.01% | +28.6% |
| Q2 2018 | $1,457,000 | -8.7% | 45,453 | -11.3% | 0.01% | -12.5% |
| Q1 2018 | $1,596,000 | -25.8% | 51,247 | +8.8% | 0.01% | -27.3% |
| Q4 2017 | $2,150,000 | +42.5% | 47,088 | +17.2% | 0.01% | +37.5% |
| Q3 2017 | $1,509,000 | -57.7% | 40,174 | -46.2% | 0.01% | -20.0% |
| Q2 2017 | $3,564,000 | – | 74,732 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |